Document Detail


Recent advances in the treatment of heart failure.
MedLine Citation:
PMID:  11999634     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment strategies for patients with heart failure and left ventricular systolic dysfunction continue to evolve as the complex pathophysiology of this disease is better understood. A number of advances have been made in recent years, most notably the addition of beta-receptor antagonists. In addition, recent studies have provided important information regarding the utility of angiotensin receptor antagonists, aldosterone receptor antagonists, and natriuretic peptides in the management of heart failure. Nonpharmacologic advances include resynchronization therapy, which appears to confer symptomatic improvement in some patients, and improvements in ventricular assist device technology. As the importance of neurohormonal activation in the progression of heart failure becomes increasingly apparent, new therapeutic strategies targeting these neurohormonal systems are being investigated.
Authors:
Ayan R Patel; Marvin A Konstam
Related Documents :
17873564 - Heart failure with preserved systolic function: giving well-deserved attention to the "...
20588214 - Emerging role of nuclear cardiology in heart failure.
25356814 - Serum ykl-40 is increased in patients with slow coronary flow.
8901684 - Medical therapy can improve the biological properties of the chronically failing heart....
22924634 - Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-a1 and it...
15151464 - Bivalirudin: an anticoagulant option for percutaneous coronary intervention.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  66     ISSN:  1346-9843     ISO Abbreviation:  Circ. J.     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-05-09     Completed Date:  2002-09-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  117-21     Citation Subset:  IM    
Affiliation:
Division of Cardiology, New England Medical Center and Tufts University, Boston, Massachusetts 02111, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Cardiomyopathy, Dilated / therapy*
Electric Countershock
Heart Failure / drug therapy,  therapy*
Humans
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Shallow groundwater quality on dairy farms with irrigated forage crops.
Next Document:  Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart...